Mahamaya Lifesciences Share Price Today | Stock Price & Mahamaya Lifesciences Share Screener
Track the current Mahamaya Lifesciences share price and stock price live with TickJournal's free stock screener. Check MAHALIFE 52-week high low for the annual price range and momentum. Use the Mahamaya Lifesciences stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Mahamaya Lifesciences opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹118 and net income of ₹5, with EBITDA of ₹10, an operating margin of 8.0% and a profit margin of 4.2%.
Mahamaya Lifesciences Share Price Chart
Track the current stock price of Mahamaya Lifesciences with an interactive chart. Analyse MAHALIFE share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Mahamaya Lifesciences stock quote in one place.
Mahamaya Lifesciences Company Profile - Fundamental Screener
Screen Mahamaya Lifesciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for MAHALIFE shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Chemicals sector and the Pesticides & Agrochemicals industry, and it trades under ISIN INE0U9D01019.
Company Details
Classification
Identifiers and Leadership
Mahamaya Lifesciences Balance Sheet Screener
Screen MAHALIFE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹310, up from ₹188 in 2025.
Latest statistics put total assets at ₹310 and shareholder funds at ₹122, with a leverage ratio of 1.52.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
Assets |
|||||
| Total Assets | 310 | 188 | 112 | 78 | 56 |
| Current Assets | 267 | 157 | 87 | 54 | 33 |
| Fixed Assets | 43 | 27 | 22 | 21 | 20 |
Liabilities |
|||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 5 | 7 | 9 | 11 | 10 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
|||||
| Total Equity | 122 | 49 | 25 | 19 | 16 |
| Share Capital | 23 | 18 | 1 | 1 | 1 |
| Reserves & Surplus | 99 | 32 | 23 | 18 | 15 |
Mahamaya Lifesciences Income Statement Screener - Profit & Revenue Analysis
Screen Mahamaya Lifesciences income statement and profit fundamentals. Analyze MAHALIFE quarterly results. Mahamaya Lifesciences reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2025-Mar, revenue was ₹118 and net profit was ₹5, equal to earnings per unit of ₹3.04, at an operating margin of 8%.
In that period expenses were ₹109, interest cost ₹3 and tax ₹2. The next period listed, 2024-Dec, shows revenue of ₹0 and net profit of ₹0.
| Item | 2025-Mar | 2024-Dec |
|---|---|---|
Revenue and Expenses | ||
| Revenue | 118 | 0 |
| Expenses | 109 | 0 |
Operating Costs and Margins | ||
| EBITDA | 10 | 0 |
| Operating Profit % | 8.00% | 0.00% |
| Depreciation | 1 | 0 |
| Interest | 3 | 0 |
Profit and Earnings | ||
| Profit Before Tax | 7 | 0 |
| Tax | 2 | 0 |
| Net Profit | 5 | 0 |
| EPS | 3.04 | 0.00 |
Mahamaya Lifesciences Cash Flow Screener - Liquidity Fundamentals
Screen MAHALIFE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2025-March, operating activities generated ₹1, and net cash flow was an inflow of ₹1.
Over the same period, investing activities used ₹8 and financing activities provided ₹9.
| Item | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|
Cash from Operations and Investing | ||||
| Operating Activities | 1 | -23 | 1 | 2 |
| Investing Activities | -8 | -2 | -3 | -3 |
Financing and Net Cash | ||||
| Financing Activities | 9 | 24 | 2 | 1 |
| Net Cash Flow | 1 | 0 | 1 | 0 |
Mahamaya Lifesciences Shareholding Pattern Screener
See Mahamaya Lifesciences shareholding pattern with promoter, FII, and DII holdings. Check Mahamaya Lifesciences promoter holding and ownership changes for MAHALIFE on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 56.35%, foreign institutions 4.77%, domestic institutions 2.52% and the public 10.65%, spread across 584 shareholders.
The shareholder count was 584 in 2026-Mar, compared with 18 in 2025-Feb.
| Item | 2026-Mar | 2025-Feb | 2025-Oct | 2025-Nov |
|---|---|---|---|---|
Promoter Holding | ||||
| Promoter Holding | 56.35% | 77.27% | 77.27% | 56.35% |
Institutional Investors | ||||
| FII Holding | 4.77% | 0.00% | 0.00% | 6.39% |
| DII Holding | 2.52% | 0.00% | 0.00% | 4.67% |
Government, Public and Others | ||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 10.65% | 0.00% | 0.00% | 12.72% |
| Other Holding | 25.71% | 22.73% | 22.73% | 19.88% |
| Shareholder Count | 584 | 18 | 18 | 1,034 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Mahamaya Lifesciences. Mahamaya Lifesciences dividend yield can be compared with peers and other stocks in the market.
Mahamaya Lifesciences Stock Index Membership - Nifty & Sensex
See which indices include Mahamaya Lifesciences stock. Check MAHALIFE index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Mahamaya Lifesciences Market Events Screener - Corporate Actions
Get Mahamaya Lifesciences corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Mahamaya Lifesciences stock events that may affect MAHALIFE share price, along with derivatives, futures and options activity and sector gainers.
3 corporate actions are listed, the most recent entry being Annual General Meeting dated September 29, 2026, with a record date of September 29, 2026.
It is followed by Quarterly Result Announcement dated May 25, 2026 and Quarterly Result Announcement dated December 2, 2025.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-29 | 2026-09-29 | Annual General Meeting | NA | -11.14% |
| 2026-05-25 | 2026-05-25 | Quarterly Result Announcement | NA | -1.16% |
| 2025-12-02 | 2025-12-02 | Quarterly Result Announcement | NA | -0.69% |
Mahamaya Lifesciences Competitors Screener - Peer Stocks Comparison
Screen MAHALIFE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Chemicals sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| UPL | 45,357 | 19.54 | 52,502 | 11.41% | 2,220 | 35.35 |
| PI Industries | 34,869 | 29.95 | 7,024 | -15.59% | 1,321 | 37.99 |
| Sumitomo Chemical | 22,035 | 37.15 | 3,385 | 3.56% | 543 | 24.89 |
| Bayer Crop Science | 16,425 | 22.12 | 5,770 | 3.16% | 689 | 13.50 |
| Sharda Cropchem | 6,544 | 10.39 | 5,410 | 23.53% | 681 | 33.33 |
| Dhanuka Agritech | 4,150 | 13.92 | 2,071 | 15.49% | 297 | 33.36 |
| Rallis | 3,873 | 31.33 | 2,631 | 6.54% | 164 | 32.48 |
| NACL Industries | 3,148 | 249.62 | 1,587 | 27.74% | 5 | 19.81 |
| Bhagiradha Chemicals & Industries | 3,119 | 112.38 | 538 | 19.68% | 18 | 29.92 |
| GSP Crop Science | 2,219 | 22.16 | 1,531 | 17.66% | 95 | 30.71 |
Mahamaya Lifesciences Company Announcements - News & Reports Screener
Screen MAHALIFE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated .
The next most recent announcements are dated October 4, 2026 and September 8, 2026.
| Date | Update | Actions |
|---|---|---|
| Shareholder Meeting / Postal Ballot-Outcome of AGM | - | |
| 2026-10-04 | Closure of Trading Window | - |
| 2026-09-08 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-07 | Reg. 34 (1) Annual Report. | - |
| 2026-09-07 | Notice Of 24Th Annual General Meeting Of The Company | - |
| 2026-09-07 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-25 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-08-25 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-08-25 | Appointment of Company Secretary and Compliance Officer | - |
| 2026-08-07 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-08-04 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-07-30 | Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer | - |
| 2026-07-10 | Non-Applicability Of The Compliance On Corporate Governance | - |
| 2026-07-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-05-26 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-05-25 | The Audited (Standalone & Consolidated) Financial Results Of The Company For The Half Year And Financial Year Ended 31.03.2026 Along With The Audit Reports Thereon | - |
| 2026-05-25 | Board Meeting Outcome for Audited Financial Results (Standalone & Consolidated) For The Half Year And Year Ended On 31.03.2026 | - |
| 2026-05-20 | Board Meeting Intimation for Prior Intimation Of The Board Meeting Pursuant To Regulation 29(1) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 | - |
| 2026-05-15 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2026-05-05 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
Frequently Asked Questions
How is the company valued right now?
The P/E ratio is 25.64 and the P/B ratio is 3.47, with earnings per unit of ₹8.33. Market capitalisation stands at ₹423.01 Cr. The company operates in the Chemicals sector, in the Pesticides & Agrochemicals industry, so compare these ratios with its sector peers in the table above.
About This Data
Key statistics were last updated on October 5, 2026. This page covers 5 balance sheet periods, 2 income statement periods, 4 cash flow years and 4 shareholding periods. Information is provided for research and is not investment advice.